HNN3.0
Register
Register
Register

Project cooperationUpdated on 28 January 2026

AI-Powered Clinical Decision Support & Digital Health Analytics | Technical Partner | Greek SME

Founder / CSO at Deeplab IKE

Athens, Greece

About

ORGANIZATION: DeepLab (Greek SME) – AI/ML for Healthcare Systems & Digital Health

WHO WE ARE:

DeepLab is a Greek SME developing custom AI-powered clinical decision support and digital health analytics. We combine predictive modeling, risk stratification, and real-time analytics with built-in interpretability—essential for clinical trust and regulatory acceptance. 15+ years research, production ML experience at scale.

CORE CAPABILITIES:

- Clinical decision support system (CDSS) development with interpretable predictions

- Predictive modeling for diagnosis, prognosis, and treatment response

- Risk stratification with fairness assessment across patient groups

- Patient subgroup identification and personalized intervention targeting

- Edge-deployed ML for mobile/wearable applications (privacy-preserving)

- Uncertainty quantification for clinical confidence levels

PUBLISHED RESEARCH:

Deep-ID (interpretable precision medicine), Deep-BCI (real-time signal processing, IEEE SMC 2023), pCCI (cell-cell interactions). All methodologies custom-adapted to partner clinical context and validation requirements.

TARGET CALLS:

- HORIZON-HLTH-2026-01-CARE-03 (Low-value care identification)

- HORIZON-HLTH-2026-01-STAYHLTH-02 (Behavioral NCDs in youth)

- HORIZON-HLTH-2026-01-DISEASE-02 (Digital technology & youth mental health)

CONSORTIUM CONTRIBUTION:

Develop custom AI analytics and decision support tools. Build interpretable predictive models with uncertainty quantification. Lead data analytics work packages. All solutions adapted to partner data, clinical workflows, and validation requirements.

KEYWORDS:

clinical decision support, CDSS, predictive modeling, risk stratification, interpretable ML, mobile health, mHealth, digital health, healthcare analytics, youth health, edge AI, Greek SME

WHY US:

Deep-tech ML with built-in explainability—not black boxes. Research rigor (15+ years) meets startup agility. We speak both algorithms and clinical reality. Greek SME adds Widening Country benefit.

SEEKING:

Health services research institutes with healthcare system access. Behavioral science groups developing digital interventions. Youth health researchers with cohort access. mHealth developers seeking AI personalization.

CONTACT: Persa Frantzi, Vassilis Pitsikalis; proposals@deeplab.ai, deeplab.ai

Topic

  • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
  • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems

Type

  • Partner seeks Consortium/Coordinator

Organisation

Deeplab IKE

Company (SME)

Athens, Greece

Similar opportunities

  • Project cooperation

    AI for Climate-Health Modeling & Environmental Risk Prediction | Technical Partner | Greek SME

    • Partner seeks Consortium/Coordinator
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health

    Vassilis Pitsikalis

    Founder / CSO at Deeplab IKE

    Athens, Greece

  • Project cooperation

    Drug Discovery, NAMs & Biomedical AI | DENVIS & ADMETrix Platforms | Greek SME DeepLab | Technical Partner

    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Vassilis Pitsikalis

    Founder / CSO at Deeplab IKE

    Athens, Greece

  • Project cooperation

    Drug Discovery, NAMs & Biomedical AI | DENVIS & ADMETrix Platforms | Greek SME DeepLab | Technical Partner

    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Persa Frantzi

    Operations and Administrative Assistant at Deeplab IKE

    Athens, Greece